Showing results (711-720 of 735) with videos related to

Sort By:
Pageof 74
Translational Andrology and Urology|February 3, 2021
Optimize the management of urological tube-related emergencies during the coronavirus disease 2019 (COVID-19) pandemicYang Luan, Yan Zhang, Kai Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2022
Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)Qinglei Gao, Jianqing Zhu, Weidong Zhao, et al.
The New England Journal of Medicine|October 15, 2025
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical CancerHua Tu, He Huang, Yanfang Li, et al.
Journal of Gynecologic Oncology|April 23, 2020
A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 studyTingyan Shi, Sheng Yin, Jianqing Zhu, et al.
The Journal of Clinical Investigation|August 31, 2021
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancerShini Liu, Qiong Zou, Jie-Ping Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian CancerNing Li, Hualei Bu, Jihong Liu, et al.
Exploration (Beijing, China)|January 1, 2026
Global Stress Responses Identify the Functionally Divergent Regulators Required for Candida auris Commensalism and PathogenicityChaoyue Xu, Wanxing Xu, Yushun Yuan, et al.
JAMA Oncology|December 30, 2020
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical TrialJunji Zhang, Yuqian Zhao, Yi Dai, et al.
Gynecologic Oncology|July 13, 2023
Prognostic significance of positive peritoneal cytology in endometrial carcinoma based on ESGO/ESTRO/ESP risk classification: A multicenter retrospective studyYue Zhang, Ran Chu, Zhaoyang Zhang, et al.
Diagnostic Pathology|January 26, 2023
Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective studyXiaohang Yang, Jingjing Yin, Yu Fu, et al.
Pageof 74